Riskpilot← Back to searchSign inGet full accessKLINIKK-SOLEO AS
ASActiveOrg 991901833Sneltvedtvegen 383, 3719 SkienOther human health activities n.e.c. · NACE 8699Est. 20073 employeeswww.soleo.no
Revenue 2024
NOK 817K
+6% vs 2023
EBITDA margin
5.4%
-60% vs 2023
Equity ratio
-89.5%
Financial strength
Net profit 2024
NOK -112K
+29% vs 2023
| Revenue | NOK 817K | +6% |
| EBITDA | NOK 44K | -60% |
| Net profit | NOK -112K | +29% |
| Total assets | NOK 1,7M | -4% |
| Equity | NOK -1,5M | -8% |
| Employees | 3 | — |
Legal name
KLINIKK-SOLEO AS
Org number
991901833
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
14. november 2007
Share capital
NOK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Alternativ medisin og rehabilitering av dyr. Eiendomsutvikling og andre tjenester som naturlig faller sammen med dette, herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.
Address
Sneltvedtvegen 383, 3719 Skien
Website
www.soleo.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 684 | 690 | 907 | 767 | 817 |
| Staff expenses | −83 | −237 | −382 | −337 | −524 |
| EBITDA | 186 | 105 | 157 | 110 | 44 |
| Depreciation & amort. | −66 | −63 | −76 | −62 | −62 |
| EBIT | 121 | 42 | 82 | 48 | −18 |
| Net financials | −119 | −111 | −173 | −206 | −95 |
| Profit before tax | 1 | −70 | −91 | −158 | −112 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 1 | −70 | −91 | −158 | −112 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 059 | 1 993 | 1 925 | 1 727 | 1 662 |
| Equity | −1 074 | −1 125 | −1 216 | −1 374 | −1 487 |
| Long-term debt | 3 089 | 3 064 | 3 075 | 3 034 | 3 057 |
| Short-term debt | 44 | 53 | 66 | 68 | 91 |
| Total debt | 3 133 | 3 117 | 3 141 | 3 102 | 3 148 |
EBITDA margin
5.4%
This company
15.8%
Market median
-66% vs market
20202024
Equity ratio
-89.5%
This company
38.2%
Market median
-334% vs market
20202024
Return on equity
-11227800.0%
This company
18.4%
Market median
-61020752% vs market
20202024
Net profit margin
-13.8%
This company
8.1%
Market median
-270% vs market
20202024
Asset turnover
0.49×
This company
1.12×
Market median
-56% vs market
20202024
Debt / equity
2.12×
This company
0.62×
Market median
-242% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MA Chief Executive Officer | Chief Executive Officer | 2010 |
FI Deputy Member | Deputy Member | 2007 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2007 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KLINIKK-SOLEO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marie Anette Tobiassen | Chief Executive Officer | 0 companies |
| Finn Ivar Hagen | Deputy Member | 0 companies |
| Jarle Jakob Hagen | Chairman | 0 companies |